To date, human genotyping efforts have identified thousands of associations between genetic variants and diseases or traits, and created maps of the unique variation within populations. Microarrays are the ideal platform for assessing known markers in the human genome, enabling researchers to find single nucleotide polymorphisms (SNPs) or larger structural changes among millions of markers.
With Illumina human genotyping arrays, you can choose expertly designed content, use consortium-developed markers, or customize array content according to your research objectives. Our array solutions provide trusted performance and support high-throughput, multiplex processing for large-scale population studies, clinical research, and other human genotyping projects.
Illumina human genotyping arrays offer several advantages.
Choose from ready-to-use human genotyping arrays with expertly designed content, or design custom iSelect or semicustom arrays to suit specific research needs. Process and scan arrays with a rapid three-day workflow.*
*Infinium XT offers a two-day workflow option.
Click on the below to view products for each workflow step.
Comprehensive microarray solution for production-scale human genotyping with flexible content.Microarray Kit Selector
Find the best kit for your needs based on project type, starting material, and method or application.
Microarray scanner for high-throughput processing of thousands of samples per day.Infinium Accessory Kits
Hardware, software, and accessories needed to process multiple array samples in parallel.
Software to help you visualize, analyze, and manage human genotyping data.Illumina Array LIMS
Laboratory information management system for high-throughput array processing and sample tracking.
Researchers perform large GWAS studies with the Global Screening Array to identify disease-associated DNA risk loci and develop PRSs for clinical validation.Read Customer Interview
Dr. Dubé and her team at the Montreal Health Institute used microarrays to identify responder genotypes in a cholesterol drug trial.Read Customer Interview
The HUNT Biobank and Lifandis AS genotyped more than 250,000 samples and searched for variants linked to myocardial infarction.Read Customer Interview
Study cancer predisposition and risk with Illumina microarrays, sequencing systems, and data analysis software. Learn more about cancer germline mutation analysis.
High-throughput DNA sequencing technologies allow researchers to rapidly screen large sample numbers to find causal variants associated with complex diseases. Learn more about causal variant discovery.